Bridging the Gulf

Biotechs eager for newly minted PhDs are finding applicants with a lack of skills in dealing in a world where science and commerce must coexist

Written byJohn Williamson
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Invitrogen hired 1,000 life science PhDs worldwide last year, of whom roughly 30% were new graduates, and it expects to hire 1,000 more by the end of this year, says Rodney Moses, vice president for global talent acquisition for the Carlsbad, Calif.-based company. Fourteen percent of recently graduating PhDs expect to join the industry within two years of their postdocs,1 yet many of these new hires aren't ready to contribute meaningfully to the companies that need them. Invitrogen managers say that "they are great scientists, but when we bring them onboard, will they also understand how we bring our products to our customers?" says Moses. The answer is too often no.

Life science PhD programs are typically geared toward allowing the student to learn enough laboratory skills to produce publishable data for the thesis, says Douglas Amorese, R&D manager for genomics business at Agilent Technologies in Palo Alto, Calif. Although ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies